Benavent, Diego http://orcid.org/0000-0001-9119-5330
Jochems, Andrea
Pascual-Salcedo, Dora
Jochems, Gijs
Plasencia-Rodríguez, Chamaida
Ramiro, Sofia
van Lankveld, Wim
Balsa, Alejandro
Navarro-Compán, Victoria
Article History
Received: 3 October 2022
Accepted: 6 February 2023
First Online: 13 February 2023
Declarations
:
: The Ethics Committee of Hospital La Paz was consulted and allowed the development study. The need for approval or informed consent was waived.
: Consent for publication from participants was obtained.
: Diego Benavent has received speaker’s honorarium from Jannsen, Roche, Grant/research support from: Novartis. Dora Pascual-Salcedo has received speaker’s honorarium from Pfizer, Menarini, Takeda, Abvvie. Grant/research support from: Pfizer, Menarini, Takeda, Abvvie. Chamaida Plasencia-Rodríguez has received speaker’s honorarium from Pfizer, Abbvie, Lilly, Sandoz, Sanofi, Biogen, Roche and Novartis, Grant/research support from: Pfizer and Abbvie. Sofia Ramiro has received speaker’s honorarium from Eli Lilly, MSD, Novartis, UCB, Consultant of: AbbVie, Eli Lilly, MSD, Novartis, Pfizer, UCB, Sanofi, Grant/research support from: AbbVie, Galapagos, Novartis, Pfizer, UCB. Alejandro Balsa has received speaker’s honorarium from Pfizer, Abbvie, Lilly, Galapagos, BMS, Sandoz, Nordic Pharma, Gebro, Roche, Sanofi, UCB, Consultant of: Pfizer, Abbvie, Lilly, Galapagos, BMS, Nordic Pharma, Sanofi, UCB, Grant/research support from: Pfizer, Abbvie, BMS, Nordic Pharma, Gebro, Roche, UCB. Victoria Navarro-Compán has received speaker’s honorarium from AbbVie, Eli Lilly, Janssen, MSD, Novartis, Pfizer, UCB Pharma, Consultant of: AbbVie, Eli Lilly, MSD, Novartis, Pfizer, UCB Pharma, Grant/research support from: AbbVie and Novartis. The rest of the authors declare that they have no conflict of interest.